27 days to first decision for reviewed manuscripts only
19 days to first decision for all manuscripts
76 days from submission to acceptance
18 days from acceptance to publication
PI3K, p38 and JAK/STAT signalling in bronchial tissue from patients with asthma following allergen challenge
Inhaled allergen challenges are often used to evaluate novel asthma treatments in early phase clinical trials. Current novel therapeutic targets in asthma include phosphoinositide 3-kinases (PI3K) delta and ga...
Citation: Biomarker Research 2018 6:14